Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma

Modern Pathology

Volumn 12, Issue 3, 1999, Pages 318-324

  Puglisi, Fabio ^a,b   Barbone, Fabio ^a   Damante, Giuseppe ^a   Bruckbauer, Michiela ^a   Di Lauro, Vincenzo ^a   Beltrami, Carlo A ^a   Di Loreto, Carla ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b Istituto di Anatomia Patologica   (Italy)

Author keywords

Immunohistochemistry; Non small cell lung carcinoma; Prognosis; Thyroid transcription factor 1

Indexed keywords

NUCLEAR PROTEIN; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 0032970313     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33:1075-107.
2. Negri E, La Vecchia C, Franceschi S, Levi S. Patterns of mortality from major cancers in Europe. Cancer Epidemiol Biomarkers Prev 1994;3:389-417.
3. Boring CC, Squires TS, Tong T. Cancer statistics. CA Cancer J Clin 1994;1994;44:7-26.
4. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; 75:191-202.
5. Ginsberg RJ, Vokes EE, Raben A. Non-small cell cancer. In: de Vita VT, Helmann S, Rosenberg SA, editors. Principles and practice of oncology. Philadelphia: Lippincott; 1997. p. 858-911.
6. Mountain CF. Revisions in the international system for staging for lung cancer. Chest 1997;111:1710-7.
7. Guazzi S, Price M, de Felice M, Damante G, Mattei MG, di Lauro R. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA-binding specificity. EMBO J 1990;9:3631-9.
8. Lazzaro D, Price M, de Felice M, di Lauro R. The transcription factor, TTF-1, is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of fetal brain. Development 1991;113:1093-104.
9. Ikeda K, Clark JC, Shaw-White JR, Stahlman MT, Boutell CJ, Whitsett JA. Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem 1995;270:8108-14.
10. Bohinski RJ, di Lauro R, Whitsett JA. The lung-specific protein B promoter is a target for thyroid transcription factor-1 and hepatocyte nuclear factor-3, indicating common factors for organ specific gene expression along the foregut. Mol Cell Biol 1994;14:5671-81.
11. Bruno MD, Bohinski RJ, Huelsman KM, Whitsett JA, Korfhagen TR. Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 1995;270:6531-6.
12. Fabbro D, di Loreto C, Stamerra O, Beltrami CA, Lo Nigro R, Damante G. TTF-1 gene expression in human lung tumours. Eur J Cancer 1996;32A:512-7.
13. Fabbro D, di Loreto C, Beltrami CA, Belfiore A, di Lauro R, Damante G. Tissue-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasm. Cancer Res 1994;54: 4744-9.
14. di Loreto C, di Lauro V, Puglisi F, Damante G, Fabbro D, Beltrami CA. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol 1997;50:30-3.
15. di Loreto C, Puglisi F, di Lauro V, Damante G, Beltrami CA. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett 1998;124:73-8.
16. Bejarano PA, Baugman RP, Biddinger PW, Miller MA, Fenoglio-Preiser C, al-Kafaji B, et al. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 1996;9:445-52.
17. Holzinger A, Dingle S, Bejarano PA, Miller MA, Weaver TE, di Lauro R, et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 1996;15:49-53.
18. World Health Organization. The World Health Organization histological typing of lung tumors. Am J Clin Pathol 1982;77: 123-36.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
20. Cox DR. Regression models and life tables. J Royal Stat Soc B 1972;34:187-220.
21. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10:60-9.
22. Minoo P, Li C, Liu HB, Hamdan H, de Lemos R. TTF-1 is an epithelial morphoregulatory transcriptional factor. Chest 1997;111:135S-137S.
23. Linnoila RI, Jensen SM, Steinberg SM, Mulshine JL, Eggleston JC, Gazdar AF. Peripheral airway cell marker expression in non-small cell lung carcinoma. Am J Clin Pathol 1992;97:233-43.
24. Rossi DL, Acebron A, Santisteban P. Function of the homeo and paired domain proteins TTF-1 and PAX-8 in thyroid cell proliferation. J Biol Chem 1995;270:23139-42.
25. Newman CS, Chia F, Krieg PA. The XHex homeobox gene is expressed during development of the vascular endothelium: overexpression leads to an increase in vascular endothelial cell number. Mech Dev 1997;66:83-93.
26. Care A, Silvani A, Meccia E, Mattia G, Stoppacciaro A, Parmiani G, et al. HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol 1996;16:4842-51.
27. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Lansdorp PM, et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 1995; 9:1753-65.
28. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. Induction of the angiogenic phenotype by HOXD3. J Cell Biol 1997;139:257-64.
29. Zannini M, Acebron A, De Felice M, Arnone MI, Martin-Perez J, Santisteban P, et al. Mapping and functional role of phosphorylation sites in the thyroid transcription factor-1 (TTF-1). J Biol Chem 1996;271:2249-54.
30. Arnone MI, Zannini M, di Lauro R. The DNA-binding activity and the dimerization ability of the thyroid transcription factor-1 are redox regulated. J Biol Chem 1995;270:12048-55.
31. Francis-Lang H, Zannini M, De Felice M, Berlinghieri MT, Fusco A, di Lauro R. Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol Cell Biol 1992;12:5793-800.